244 related articles for article (PubMed ID: 27004457)
1. Prognostic factors and disease-specific survival among immigrants diagnosed with cutaneous malignant melanoma in Sweden.
Simberg-Danell C; Lyth J; Månsson-Brahme E; Frohm-Nilsson M; Carstensen J; Hansson J; Eriksson H
Int J Cancer; 2016 Aug; 139(3):543-53. PubMed ID: 27004457
[TBL] [Abstract][Full Text] [Related]
2. Low level of education is associated with later stage at diagnosis and reduced survival in cutaneous malignant melanoma: a nationwide population-based study in Sweden.
Eriksson H; Lyth J; Månsson-Brahme E; Frohm-Nilsson M; Ingvar C; Lindholm C; Naredi P; Stierner U; Wagenius G; Carstensen J; Hansson J
Eur J Cancer; 2013 Aug; 49(12):2705-16. PubMed ID: 23583439
[TBL] [Abstract][Full Text] [Related]
3. Later stage at diagnosis and worse survival in cutaneous malignant melanoma among men living alone: a nationwide population-based study from Sweden.
Eriksson H; Lyth J; Månsson-Brahme E; Frohm-Nilsson M; Ingvar C; Lindholm C; Naredi P; Stierner U; Carstensen J; Hansson J
J Clin Oncol; 2014 May; 32(13):1356-64. PubMed ID: 24687828
[TBL] [Abstract][Full Text] [Related]
4. Reduced disease-specific survival following a diagnosis of multiple primary cutaneous malignant melanomas-a nationwide, population-based study.
Utjés D; Lyth J; Lapins J; Eriksson H
Int J Cancer; 2017 Dec; 141(11):2243-2252. PubMed ID: 28799271
[TBL] [Abstract][Full Text] [Related]
5. Cutaneous malignant melanoma show geographic and socioeconomic disparities in stage at diagnosis and excess mortality.
Strömberg U; Peterson S; Holmberg E; Holmén A; Persson B; Sandberg C; Nilbert M
Acta Oncol; 2016 Aug; 55(8):993-1000. PubMed ID: 26935355
[TBL] [Abstract][Full Text] [Related]
6. Trends in cutaneous malignant melanoma in Sweden 1997-2011: thinner tumours and improved survival among men.
Lyth J; Eriksson H; Hansson J; Ingvar C; Jansson M; Lapins J; Månsson-Brahme E; Naredi P; Stierner U; Ullenhag G; Carstensen J; Lindholm C
Br J Dermatol; 2015 Mar; 172(3):700-6. PubMed ID: 25323770
[TBL] [Abstract][Full Text] [Related]
7. Prognostic instrument for survival outcome in melanoma patients: based on data from the population-based Swedish Melanoma Register.
Lyth J; Mikiver R; Nielsen K; Isaksson K; Ingvar C
Eur J Cancer; 2016 May; 59():171-178. PubMed ID: 27046697
[TBL] [Abstract][Full Text] [Related]
8. Prognostic risk factors of first recurrence in patients with primary stages I-II cutaneous malignant melanoma - from the population-based Swedish melanoma register.
Lyth J; Falk M; Maroti M; Eriksson H; Ingvar C
J Eur Acad Dermatol Venereol; 2017 Sep; 31(9):1468-1474. PubMed ID: 28419674
[TBL] [Abstract][Full Text] [Related]
9. The proportion cured of patients diagnosed with Stage III-IV cutaneous malignant melanoma in Sweden 1990-2007: A population-based study.
Eriksson H; Lyth J; Andersson TM
Int J Cancer; 2016 Jun; 138(12):2829-36. PubMed ID: 26815934
[TBL] [Abstract][Full Text] [Related]
10. Epidemiology of cutaneous melanoma in Sweden-Stage-specific survival and rate of recurrence.
Rockberg J; Amelio JM; Taylor A; Jörgensen L; Ragnhammar P; Hansson J
Int J Cancer; 2016 Dec; 139(12):2722-2729. PubMed ID: 27563839
[TBL] [Abstract][Full Text] [Related]
11. Breast cancer diagnosis and mortality by tumor stage and migration background in a nationwide cohort study in Sweden.
Abdoli G; Bottai M; Sandelin K; Moradi T
Breast; 2017 Feb; 31():57-65. PubMed ID: 27810701
[TBL] [Abstract][Full Text] [Related]
12. Stage-specific direct health care costs in patients with cutaneous malignant melanoma.
Lyth J; Carstensen J; Synnerstad I; Lindholm C
J Eur Acad Dermatol Venereol; 2016 May; 30(5):789-93. PubMed ID: 25807966
[TBL] [Abstract][Full Text] [Related]
13. Estimating the cure proportion of malignant melanoma, an alternative approach to assess long term survival: a population-based study.
Andersson TM; Eriksson H; Hansson J; Månsson-Brahme E; Dickman PW; Eloranta S; Lambe M; Lambert PC
Cancer Epidemiol; 2014 Feb; 38(1):93-9. PubMed ID: 24447700
[TBL] [Abstract][Full Text] [Related]
14. Conditional recurrence-free survival in patients with primary stage I-II cutaneous malignant melanoma - a population-based study.
Lyth J
Melanoma Res; 2018 Dec; 28(6):637-640. PubMed ID: 29994850
[TBL] [Abstract][Full Text] [Related]
15. Urolithiasis in immigrant groups: a nationwide cohort study in Sweden.
Wändell P; Carlsson AC; Li X; Gasevic D; Sundquist J; Sundquist K
Scand J Urol; 2019 Feb; 53(1):69-76. PubMed ID: 30958074
[No Abstract] [Full Text] [Related]
16. Prognostic factors in localized invasive primary cutaneous malignant melanoma: results of a large population-based study.
Eriksson H; Frohm-Nilsson M; Järås J; Kanter-Lewensohn L; Kjellman P; Månsson-Brahme E; Vassilaki I; Hansson J
Br J Dermatol; 2015 Jan; 172(1):175-86. PubMed ID: 24910143
[TBL] [Abstract][Full Text] [Related]
17. Parkinson's Disease Among Immigrant Groups and Swedish-Born Individuals: A Cohort Study of All Adults 50 Years of Age and Older in Sweden.
Wändell P; Fredrikson S; Carlsson AC; Li X; Sundquist J; Sundquist K
J Parkinsons Dis; 2020; 10(3):1133-1141. PubMed ID: 32568106
[TBL] [Abstract][Full Text] [Related]
18. Atrial fibrillation in immigrant groups: a cohort study of all adults 45 years of age and older in Sweden.
Wändell P; Carlsson AC; Li X; Gasevic D; Ärnlöv J; Holzmann MJ; Sundquist J; Sundquist K
Eur J Epidemiol; 2017 Sep; 32(9):785-796. PubMed ID: 28702880
[TBL] [Abstract][Full Text] [Related]
19. No influence of immigrant background on the outcome of total hip arthroplasty. 140,299 patients born in Sweden and 11,539 immigrants in the Swedish Hip Arthroplasty Register.
Krupic F; Eisler T; Eliasson T; Garellick G; Gordon M; Kärrholm J
Acta Orthop; 2013 Feb; 84(1):18-24. PubMed ID: 23343377
[TBL] [Abstract][Full Text] [Related]
20. End-Stage Kidney Diseases in Immigrant Groups: A Nationwide Cohort Study in Sweden.
Wändell P; Carlsson AC; Li X; Gasevic D; Ärnlöv J; Sundquist J; Sundquist K
Am J Nephrol; 2019; 49(3):186-192. PubMed ID: 30712037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
